News

REACH

Review of extended one-generation reproductive toxicity studies

Next year, ECHA starts to review extended one-generation reproductive toxicity (EOGRT) studies that registrants have submitted following a dossier or substance evaluation decision. The EOGRT study has been the new information requirement for reproductive toxicity under REACH since March 2015.

The aim is to:

analyse the extent to which studies meet the regulatory expectations;
inform on potential concerns, such as for endocrine-disrupting properties; and
analyse the study expansions (production of the second filial generation, developmental neurotoxicity and immunotoxicity) and the relationship with regulatory triggers under REACH.

ECHA runs the project with support from Member States. Other stakeholders may also be consulted. The final report is expected in 2023.

36 new testing proposals for consultation

ECHA has published 36 new testing proposals and invites stakeholders to submit scientifically valid information and studies by 7 January 2021.

Testing proposals

Submission of DMAC and NEP restriction report postponed

The Netherlands' submission of the restriction report on N,N-dimethylacetamide (DMAC) (EC 204-826-4, CAS 127-19-5) and 1-ethylpyrrolidin-2-one (NEP) (EC 220-250-6, CAS 2687-91-4) has been postponed until 1 October 2021.

Registry of restriction intentions

Biocides

Watch the webinar recording on IUCLID 6.5 for biocides users

The webinar outlines the format changes and improvements in IUCLID 6.5 related to biocides and introduces a new dossier type for technical equivalence.

The recording and presentations are now available.

Webinar recording

Waste

Did you miss our webinar on SCIP notifications?

The webinar helps you prepare and submit SCIP notifications and shows the tools you can use to refer to information already submitted to the SCIP database. The recording and presentations are now available.

Webinar recording l SCIP database

Board of Appeal

First Board of Appeal decision on technical equivalence

For the first time, an appeal was lodged against a decision where ECHA rejected an application for establishing the technical equivalence of active substances under Article 54 of the Biocidal Products Regulation.

The Board of Appeal found that ECHA breached the right to good administration in two respects:

ECHA failed to specify clearly and comprehensively what additional information it needed to carry out the assessment of technical equivalence.
ECHA breached the appellant’s right to be heard as its decision was partly based on considerations on which the appellant had no opportunity to make its views known.

The Board of Appeal annulled the decision and remitted the case to ECHA for further action.

Board of Appeal's decision